NASDAQ:GRTX - Nasdaq - US36338D1081 - Common Stock - Currency: USD
Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galera Therapeutics (NASDAQ:GRTX) just reported results for the second quarter ...
Galera Therapeutics just reported results for the second quarter of 2024.
Company reports second quarter 2024 financial results...
Company reports second quarter 2024 financial results
Galera Therapeutics just reported results for the first quarter of 2024.
GRTX stock results show that Galera Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Galera's First Quarter 2024 Earnings Release...
Company’s evaluation of potential strategic alternatives progresses with goal to maximize stockholder value
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of...
It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday!
Company continues to evaluate strategic options to maximize shareholder value...
Company continues to evaluate strategic options to maximize shareholder value
The biggest pre-market stock movers for Wednesday are ready to go as we break down all of the latest news moving shares today!